Supine hypertension in Parkinson's disease and multiple system atrophy.
about
Multiple system atrophy: insights into a rare and debilitating movement disorder.Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease.The Clinical Autonomic Research journal 2017 and onward.Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy.Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease.Managing neurogenic orthostatic hypotension with droxidopa in a patient with Parkinson disease, atrial fibrillation, and hypertension.Initiating droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease.Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus.Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms.Diagnosis of multiple system atrophy.Acute cyclooxygenase inhibition and baroreflex sensitivity in lean and obese adults.Structural and functional alterations of the heart in Parkinson's disease.Treatment of supine hypertension in autonomic failure: a case series.Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) : Endorsed by the European Academy of Neurol
P2860
Q39183459-BAE22319-CF51-40A0-95FC-1B6F98716E65Q42324086-094CBFED-493F-41D0-A317-5E69BA3D7377Q42333955-F33FA80E-0743-4113-BFBB-8D18107C8098Q42336393-4895E449-6EF0-43E3-BEC9-1D6EEF068F9DQ42336396-859D7623-C6D9-4057-A11D-7A89EF34925BQ42336400-AE7DB15A-8F5E-47F0-908B-4BAAA4E2D642Q42336401-CF3D3296-411E-43FC-92BC-F7FBC7E700D5Q42336403-524A10F0-F506-44D9-A873-B9A917E1830BQ44746489-DC3006E6-7917-4491-ACE3-256515DF1F36Q47665262-11EF11D2-6AD4-432C-B3C4-D159B8155B70Q47948834-0598084B-9059-4EA8-A184-07EC797858BEQ50066781-E00C5EC1-FB47-4EBC-9179-E5BD1F056C06Q50101682-90A07F7F-2628-4FC1-A84F-75E0AA958B47Q52672547-77689DA8-138F-4AC1-8790-6144D84F37BBQ56382514-2A87835C-A540-4E62-95F1-EDA48FEE5D32
P2860
Supine hypertension in Parkinson's disease and multiple system atrophy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Supine hypertension in Parkinson's disease and multiple system atrophy.
@en
Supine hypertension in Parkinson's disease and multiple system atrophy.
@nl
type
label
Supine hypertension in Parkinson's disease and multiple system atrophy.
@en
Supine hypertension in Parkinson's disease and multiple system atrophy.
@nl
prefLabel
Supine hypertension in Parkinson's disease and multiple system atrophy.
@en
Supine hypertension in Parkinson's disease and multiple system atrophy.
@nl
P2093
P2860
P50
P1476
Supine hypertension in Parkinson's disease and multiple system atrophy.
@en
P2093
Alessandra Fanciulli
Francesco E Pontieri
Georg Göbel
Jean Pierre Ndayisaba
Roberta Granata
Stefano Strano
Susanne Duerr
P2860
P2888
P304
P356
10.1007/S10286-015-0336-4
P577
2016-01-22T00:00:00Z